Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Phreesia Inc (PHR)

Phreesia Inc (PHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 557,197
  • Shares Outstanding, K 60,763
  • Annual Sales, $ 480,590 K
  • Annual Income, $ 2,310 K
  • EBIT $ 25 M
  • EBITDA $ 60 M
  • 60-Month Beta 0.86
  • Price/Sales 1.16
  • Price/Cash Flow 12.29
  • Price/Book 1.64

Options Overview Details

View History
  • Implied Volatility 52.64% (-8.69%)
  • Historical Volatility 104.35%
  • IV Percentile 41%
  • IV Rank 14.80%
  • IV High 123.18% on 03/20/26
  • IV Low 40.39% on 07/17/25
  • Expected Move (DTE 24) 0.68 (7.21%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4,315
  • Volume Avg (30-Day) 692
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 10,090
  • Open Int (30-Day) 11,500
  • Expected Range 8.75 to 10.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate $0.06
  • Number of Estimates 4
  • High Estimate $0.17
  • Low Estimate $-0.02
  • Prior Year $-0.07
  • Growth Rate Est. (year over year) +185.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.77 +21.36%
on 03/31/26
12.29 -23.27%
on 03/23/26
-2.43 (-20.49%)
since 03/20/26
3-Month
7.77 +21.36%
on 03/31/26
16.03 -41.17%
on 01/26/26
-6.30 (-40.05%)
since 01/20/26
52-Week
7.77 +21.36%
on 03/31/26
32.76 -71.21%
on 08/28/25
-14.54 (-60.66%)
since 04/17/25

Most Recent Stories

More News
Rosen Law Firm Encourages Phreesia, Inc. Investors to Inquire About Securities Class Action Investigation – PHR

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Phreesia, Inc. (NYSE: PHR) resulting from...

PHR : 9.43 (+2.84%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Phreesia, Inc. - PHR

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR).  Such investors are advised to...

PHR : 9.43 (+2.84%)
PHR Investor Alert: Phreesia Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing To Fully Disclose Weakening Revenue Visibility: Levi & Korsinsky

Phreesia guided FY 2027 revenue at $545-$559 million while internal visibility into key segments was already deteriorating -- shareholders who lost money when the guidance was slashed to $510-$520 million...

PHR : 9.43 (+2.84%)
Phreesia Named to Becker’s Hospital Review’s 2026 List of “Revenue Cycle Management Companies to Know”

Phreesia, a leader in patient intake, outreach and activation, has been named to Becker’s Hospital Review ’s 2026 list of “ Revenue Cycle Management Companies...

PHR : 9.43 (+2.84%)
Investigation Underway: Phreesia, Inc. (PHR) - Contact Levi & Korsinsky Over Securities Law Violations

New York, New York--(Newsfile Corp. - April 13, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential...

PHR : 9.43 (+2.84%)
MediFind Becomes First Doctor Directory to Receive the Digital Medicine Society Seal

MediFind, a leading data-powered online provider directory, is proud to announce it received the DiMe Seal , developed by the Digital Medicine Society...

PHR : 9.43 (+2.84%)
Protect Your Investment: Contact Levi & Korsinsky About the Phreesia, Inc. (PHR) Investigation

New York, New York--(Newsfile Corp. - April 8, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE:PHR) concerning potential...

PHR : 9.43 (+2.84%)
PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: ...

PHR : 9.43 (+2.84%)
Phreesia Hits Bottom in Q1: Rebound Ahead, Timing Uncertain

Phreesia is well-positioned to capture growth and market share but faces headwinds as visibility dims and questions arise.

PHR : 9.43 (+2.84%)
Investors in Phreesia, Inc. (PHR) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - April 1, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential...

PHR : 9.43 (+2.84%)

Business Summary

Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based...

See More

Key Turning Points

3rd Resistance Point 10.05
2nd Resistance Point 9.76
1st Resistance Point 9.59
Last Price 9.43
1st Support Level 9.13
2nd Support Level 8.84
3rd Support Level 8.67

See More

52-Week High 32.76
Fibonacci 61.8% 23.21
Fibonacci 50% 20.26
Fibonacci 38.2% 17.32
Last Price 9.43
52-Week Low 7.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.